Skincare enthusiasts are delaying their Botox appointments thanks to a bestselling Medik8 serum that has been reduced by 25% in a new sale. The Medik8 Liquid Peptides 30% Complex Multi-Peptide Age-Defying Serum, now priced at £44.25 down from £59, has become a firm favourite among beauty fans who praise its smoothing and brightening effects.
The serum, designed for early signs of ageing, combines ten peptides in a concentrated 30% blend to help slow and prevent the formation of fine lines. According to an independent eight-week consumer study involving 60 participants, it is clinically shown to visibly smooth the look of fine lines within just seven days. The formula also uses 'drone-targeted technology' to deliver the peptide blend to where it is most effective, while boosting the skin's natural hyaluronic acid levels for improved hydration.
The brand recommends applying six drops to the face, neck and décolletage in the morning and evening after cleansing, allowing it to absorb fully before following with a moisturiser. Medik8 has received a 4.9 out of five-star rating on its website, based on nearly 2,000 reviews, with one customer writing: "I love these products! It's normally the time I would get Botox and I literally can put it off! I get compliments on my skin frequently."
Another shopper reported "excellent results, definite fast improvement", while a third said: "Great product - giving your skin an instant feeling of well-being. I understand it's good for wrinkles too, although, I wouldn't know about that, as I'm only in my seventies and don't have wrinkles." However, some were less convinced, with one user noting they hadn't seen dramatic changes but were impressed by the texture and absorption, and another saying the product "doesn't go very far".
For those seeking alternatives, L'Oreal Paris Age Perfect Serum Le Duo 30ml is available for £18.99 (down from £37.99) at Boots, while Zelens Youth Intelligence Age-Defying Serum 30ml is priced at £91 (down from £130) at LookFantastic, offering a more luxurious option with a 4.7-star rating.
